絞り込み

16610

広告

「現役女子高生 ピル飲んでます」誤解解いて ツイートに反響 (NHK)

女性の生理の痛みなどを和らげる治療薬としての低用量ピル。しかし避妊目的のイメージが強く、生理痛の治療に使うことが知られていないため、つらい思いをしたと訴える女子...

  1. ペンギンたちが大集合 (日経BP)
  2. [医学] 32の抗精神病薬の統合失調症治...
  3. 薬局で妊産婦の薬の一元的・継続的な把握を...
  4. 薬を交付した薬局薬剤師の言い分 (日経B...

ニュース一覧

「elotuzumab」の検索結果

230件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Increased SLAMF7 monocytes in myelofibrosis patients harboring JAK2V617F provide a therapeutic target of elotuzumab.

Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.

Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient.

[Treatment of multiple myeloma with elotuzumab plus pomalidomide and dexamethasone].

A U.S. Cost Analysis of Triplet Regimens for Patients with Previously Treated Multiple Myeloma.

Immunotherapy in myeloma: how far have we come?

Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data.

[Successful Treatment with Pomalidomide, Bortezomib, and Dexamethasone in a Patient with Frail Refractory and Relapsed Multiple Myeloma with Extramedullary Disease].

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update.

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy.

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients.

Second elotuzumab triplet efficacious in MM.

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.

Elotuzumab in multiple myeloma.

Clinical impact of serum soluble SLAMF7 in multiple myeloma.

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.

Hematologic Malignancies: Plasma Cell Disorders.

2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer.

Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります